business

SEBI members bat for phased reduction of STT

by

In a move to increase the depth of the capital markets, members of the Securities and Exchange Board of India (SEBI) have recommended a phased reduction of the securities transaction tax (STT). The recommendation has come in the wake of discussions with finance minister Pranab Mukherjee. To increase retail investors’ participation by lowering STT is … Read more SEBI members bat for phased reduction of STT

RCOM seeking shareholder approval for QIP

by

RCOM is seeking shareholders’ approval to raise funds through equity/equity-linked instruments which could result in potential equity dilution of up to 25%. As per the company, the funds would enable it to strengthen its balance sheet and equip it to participate in the upcoming 3G/Wi-Max auctions. 3G/Wi-Max auctions have been announced as one of the … Read more RCOM seeking shareholder approval for QIP

India’s April Trade Data Doesn’t Change Rupee View against USD

by

India’s April 2009 exports fell 33.2% yoy, while imports fell 36.3% (non-oil imports fell 24.6%, compared to a 58.4% fall in oil imports): India’s trade data for April released today continues to validate our forecasts that India’s imports would fall faster than exports in the 1H of calendar 2009 narrowing the trade deficit. We hold … Read more India’s April Trade Data Doesn’t Change Rupee View against USD

Glenmark gets nod from USFDA for Hydralazine Hydrochloride Tablets

by

Glenmark Generics Inc USA, a subsidiary of Glenmark Generics, has received ANDA approval from USFDA for Hydralazine Hydrochloride tablets. The product will be available in dosages of 10mg, 25mg, 50mg and 100mg. The company will start marketing and shipping the product within US market soon. Hydralazine Hydrochloride tablets are used for the treatment of essential … Read more Glenmark gets nod from USFDA for Hydralazine Hydrochloride Tablets